Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
Pharmabiz15h
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...
Sepsis molecule discovery could lead to improved treatments for critically ill patients
Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...
pulmonologyadvisor5h
Study Suggests Lanadelumab Effective as LTP in Patients With HAE
Lanadelumab has been found to be effective as long-term prophylaxis in reducing attack frequency in patients with HAE.
Amgen: FDA Approves Lumakras (sotorasib) In Combination With Vectibix (panitumumab) For Chemorefractory Kras G12c-mutated Metastatic Colorectal Cancer
Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...